, Singapore

Daily Markets Briefing: STI punched through the 3405 mark

Index poised for a positive start today.

OCBC Investment Research said:

With both the US and European markets reaching fresh new highs overnight, this is likely to cue the local bourse to a positive start this morning as well.

Following a few short sessions of consolidation, the STI punched through the 3405 immediate resistance yesterday.

This could set the stage for the index to recover further towards the 3485 obstacle in the days ahead, while the next resistance lies at the 3500 psychological hurdle.

On the downside, the immediate support is now pegged at the 3405 resistance-turned-support, followed by the next base at the 3365 recent trough.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare